- Home
- LYTS vs EVMN Comparison
LYTS vs EVMN Comparison
Compare LYTS & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LYTS | EVMN |
|---|---|---|
| Founded | 1976 | 2020 |
| Country | United States | United States |
| Employees | N/A | 48 |
| Industry | Building Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 698.9M | 825.5M |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | LYTS | EVMN |
|---|---|---|
| Price | $23.07 | $22.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | $27.50 | ★ $43.88 |
| AVG Volume (30 Days) | ★ 490.9K | 341.8K |
| Earning Date | 04-23-2026 | 06-11-2026 |
| Dividend Yield | ★ 0.87% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.48 | N/A |
| Revenue | ★ $573,377,000.00 | N/A |
| Revenue This Year | $16.20 | N/A |
| Revenue Next Year | $27.71 | N/A |
| P/E Ratio | $46.94 | ★ N/A |
| Revenue Growth | ★ 22.09 | N/A |
| 52 Week Low | $15.62 | $13.89 |
| 52 Week High | $24.99 | $33.20 |
Technical Indicators
Market Signals| Indicator | LYTS | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 53.89 | 45.97 |
| Support Level | $21.76 | $21.39 |
| Resistance Level | $23.84 | $23.08 |
| Average True Range (ATR) | 0.76 | 1.43 |
| MACD | -0.28 | -0.01 |
| Stochastic Oscillator | 37.79 | 45.87 |
Price Performance
Historical ComparisonAbout LYTS LSI Industries Inc.
LSI Industries Inc provides corporate visual image solutions to the petroleum and convenience store industry. The company's operating segments include Lighting and Display Solutions. It generates maximum revenue from the Display solutions segment. Lighting Segment manufactures and markets outdoor and indoor lighting and lighting controls for the commercial, industrial, and multi-site retail markets, including the petroleum/convenience store, quick-service, and automotive markets. The Display Solutions Segment manufactures, sells, and installs exterior and interior visual image and display elements, including printed graphics, structural graphics, digital signage, menu board systems, display fixtures, refrigerated displays, and custom display elements.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.